NJ State Employees Deferred Compensation Plan’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,500
Closed -$258K 163
2025
Q3
$258K Hold
4,500
0.03% 375
2025
Q2
$266K Hold
4,500
0.03% 363
2025
Q1
$329K Hold
4,500
0.04% 344
2024
Q4
$372K Hold
4,500
0.05% 337
2024
Q3
$322K Hold
4,500
0.04% 361
2024
Q2
$308K Hold
4,500
0.04% 362
2024
Q1
$241K Hold
4,500
0.03% 407
2023
Q4
$240K Hold
4,500
0.03% 408
2023
Q3
$223K Buy
+4,500
New +$252K 0.03% 405

Other funds holding GMED

NJ State Employees Deferred Compensation Plan's GMED Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 4,500 shares — an estimated $258K sold.

NJ State Employees Deferred Compensation Plan first reported a position in GMED in Q3 2023 and held it in 9 quarters. The position peaked at $372K in Q4 2024. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • NJ State Employees Deferred Compensation Plan reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 4,500 Globus Medical shares in Q4 2025, an estimated $258K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Globus Medical in Q3 2023 and held it in 9 quarters.
  • NJ State Employees Deferred Compensation Plan's Globus Medical position peaked at $372K in Q4 2024.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.